Compare 10X Genomics Inc (TXG) vs Vertiv Holdings Co (VRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Vertiv Holdings Co — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Vertiv Holdings Co trades at $305.58 (market cap $112.03B). The key difference: Vertiv Holdings Co is far larger — about 20.4× 10X Genomics Inc's market cap, and Vertiv Holdings Co pays a 0.09% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | VRT | |
|---|---|---|
Market Cap | $5.48B | $112.03B |
Sector | Health | Technology |
52-Week High | $45.80 | $376.23 |
52-Week Low | $11.34 | $121.82 |
Enterprise Value | $5.02B | $112.80B |
Dividend Yield | — | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →
